Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
AZN:LSE since
announced
Transaction
value
Fusion Pharmaceuticals IncAnnounced19 Mar 202419 Mar 2024Announced9.50%2.30bn
Amolyt Pharma SASAnnounced14 Mar 202414 Mar 2024Announced7.75%1.05bn
Gracell Biotechnologies IncDeal completed26 Dec 202326 Dec 2023Deal completed7.97%1.10bn
Icosavax IncDeal completed12 Dec 202312 Dec 2023Deal completed11.61%862.87m
Data delayed at least 20 minutes, as of Apr 23 2024 18:45 BST.

Institutional shareholders

0.00%Per cent of shares held by top holders
HolderShares% Held
Da Cheng Fund Management Co., Ltd.as of 30 Jun 20230.000.00%
Data from 30 Jun 2023 - 30 Jun 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.